Probiotics with digestive enzymes for dogs: What does the evidence show?

Answer-first summary

MIXED

Specific probiotics have mixed canine clinical evidence, while general digestive-enzyme supplementation outside diagnosed pancreatic insufficiency has limited direct clinical evidence. Exact-product efficacy is not established.

What is being evaluated

This page evaluates the ingredient/formula-level canine evidence for products combining a probiotic with digestive enzymes, without a listed prebiotic fiber component.

Relevant ingredient or formula types

Probiotic strains combined with digestive enzymes (e.g., protease, amylase, lipase, cellulase), without an added prebiotic fiber component.

What has been studied

• Jensen AP, Bjørnvad CR. Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review. J Vet Intern Med. 2019;33(5):1849-1864. Systematic review: canine probiotic GI evidence was heterogeneous; effects were generally limited and trials often small or at risk of bias. https://pubmed.ncbi.nlm.nih.gov/31313372/
• Gómez-Gallego C, et al. A canine-specific probiotic product in treating acute or intermittent diarrhea in dogs: A double-blind placebo-controlled efficacy study. Vet Microbiol. 2016. Specific canine-derived Lactobacillus formulation improved stool consistency in a randomized placebo-controlled study; strain/formulation specificity limits generalization. https://pubmed.ncbi.nlm.nih.gov/27938673/
• Shmalberg J, et al. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front Vet Sci. 2019. Randomized trial did not detect a statistically significant difference in diarrhea resolution between probiotic, metronidazole and placebo groups. https://pubmed.ncbi.nlm.nih.gov/31275948/

Limitations and conflicting evidence

Amazon listing content is used only to identify listed ingredients/form and product positioning. It is not treated as scientific evidence. Customer rating, review volume and recent-purchase signals are used only for the separate popularity model and are not part of this evidence review.

How to interpret commercial products

Evidence for an ingredient, strain, extract, or formula category should not be treated as evidence that every commercial product containing it will produce the same result. Applicability depends on the studied preparation, dose, co-ingredients, population, duration, and outcome measures.

Practical interpretation

MIXED describes the current evidence for this ingredient or formula entity; it is not a product recommendation. The most reliable use of this page is to compare a commercial label with the intervention that was actually studied, while keeping the study population and limitations in view.

References

1. Jensen AP, Bjørnvad CR. Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review. J Vet Intern Med. 2019;33(5):1849-1864. Systematic review: canine probiotic GI evidence was heterogeneous; effects were generally limited and trials often small or at risk of bias. https://pubmed.ncbi.nlm.nih.gov/31313372/
2. Gómez-Gallego C, et al. A canine-specific probiotic product in treating acute or intermittent diarrhea in dogs: A double-blind placebo-controlled efficacy study. Vet Microbiol. 2016. Specific canine-derived Lactobacillus formulation improved stool consistency in a randomized placebo-controlled study; strain/formulation specificity limits generalization. https://pubmed.ncbi.nlm.nih.gov/27938673/
3. Shmalberg J, et al. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front Vet Sci. 2019. Randomized trial did not detect a statistically significant difference in diarrhea resolution between probiotic, metronidazole and placebo groups. https://pubmed.ncbi.nlm.nih.gov/31275948/